Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 8/20 | 0.77 |
| ▸ | USP10 | Q14694 | 1/20 | 0.64 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.64 |
| ▸ | USP13 | Q92995 | 1/20 | 0.64 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | EGFR | P00533 | 1/20 | 0.52 |
| ▸ | APP | P05067 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | CCNC | P24863 | 1/20 | 0.52 |
| ▸ | CDKN1A | P38936 | 1/20 | 0.52 |
| ▸ | CDK8 | P49336 | 1/20 | 0.52 |
| ▸ | CDK19 | Q9BWU1 | 1/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.52 |
| ▸ | GALR3 | O60755 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13171085 | 0.93 | HTT (0.67) | HTTUSP10PIK3C3USP13NR2F2 | |
| SCHEMBL9921352 | 0.87 | HTT (0.81) | HTTUSP10PIK3C3USP13NR2F2 | |
| SCHEMBL13191858 | 0.87 | HTT (1.00) | HTTUSP10PIK3C3USP13NR2F2 | |
| SCHEMBL13170963 | 0.87 | USP10 (0.84) | HTTUSP10PIK3C3USP13LMNA | |
| SCHEMBL9921359 | 0.86 | HTT (0.72) | HTTUSP10PIK3C3USP13NR2F2 | |
| SCHEMBL9921379 | 0.86 | HTT (0.65) | HTTUSP10PIK3C3USP13MAPK1 | |
| SCHEMBL13171176 | 0.86 | HTT (0.69) | HTTUSP10PIK3C3USP13NR2F2 | |
| SCHEMBL9921377 | 0.85 | HTT (0.74) | HTTUSP10PIK3C3USP13NR2F2 | |
| SCHEMBL19160676 | 0.85 | HTT (0.85) | HTTNR2F2MAPK1LMNAEGFR | |
| SCHEMBL9921342 | 0.85 | HTT (0.73) | HTTUSP10PIK3C3USP13NR2F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9393244-B2 | Increasing parkin activity by administering a deubiquitinating enzyme inhibitor | GEORGETOWN UNIVERSITY (US) | 2016-07-19 | — | — | US | disclosed |
| US-20140271668-A1 | INCREASING PARKIN ACTIVITY BY ADMINISTERING A DEUBIQUITINATING ENZYME INHIBITOR | GEORGETOWN UNIVERSITY (US) | 2014-09-18 | — | — | US | disclosed |
| US-20120258975-A1 | Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof | SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY (CN) | 2012-10-11 | — | — | US | disclosed |
| US-20120258975-A1 | Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof | SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY (CN) | 2012-10-11 | — | — | US | disclosed |
| WO-2012079079-A1 | PRODUCTION OF INDUCED PLURIPOTENT STEM CELLS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2012-06-14 | — | — | WO | disclosed |
| WO-2011011522-A2 | POTENT SMALL MOLECULE INHIBITORS OF AUTOPHAGY, AND METHODS OF USE THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2011-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120258975-A1 | Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof | ATG7, BECN1, SQSTM1 | HTT 4078/4885USP10 1695/4885PIK3C3 186/4885 |
| US-20140271668-A1 | INCREASING PARKIN ACTIVITY BY ADMINISTERING A DEUBIQUITINATING ENZYME INHIBITOR | UBQLN1, UBQLN2, PARK7 | HTT 131/4885USP10 26/4885PIK3C3 1286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.